Edition:
United Kingdom

People: Abcam PLC (ABCA.L)

ABCA.L on London Stock Exchange

1,423.00GBp
11:26am BST
Change (% chg)

29.00 (+2.08%)
Prev Close
1,394.00
Open
1,390.00
Day's High
1,425.00
Day's Low
1,390.00
Volume
244,056
Avg. Vol
422,420
52-wk High
1,643.80
52-wk Low
1,006.00

Allen, Peter 

Mr. Peter Vance Allen is Non-Executive Chairman of the Board of the Company. Peter has over 20 years’ experience as an executive director, non-executive director and chairman in a wide range of life science companies playing a significant role in their growth. He spent three years as Chairman of Proximagen Neurosciences plc (2009-2012), six years at ProStaken Group plc as Chairman (2007–2013) and interim CEO (2010–2011) and twelve years at Celltech Group plc (1992–2004) as CFO and Deputy CEO. Peter is currently Non-Executive Chairman of AIM listed Advanced Medical Solutions plc, Clinigen plc and Diurnal plc and privately-owned Oxford Nanopore Technologies Ltd. He is a Non-Executive Director of Istesso Ltd. A chartered accountant by background, Peter is an experienced chairman and board member and has substantial experience in M&A, international growth, fundraising and investor relations, as well as the commercialisation of intellectual property.

Basic Compensation

Total Annual Compensation, GBP 9,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 9,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Peter Allen

9,000

Alan Hirzel

1,788,000

Jonathan Milner

70,000

Gavin Wood

666,000

Marc Perkins

--

Giles Kerr

--
As Of  30 Jun 2018